{"id":62328,"date":"2025-12-09T19:05:56","date_gmt":"2025-12-09T18:05:56","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/"},"modified":"2025-12-09T19:05:56","modified_gmt":"2025-12-09T18:05:56","slug":"analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/","title":{"rendered":"Analysis Shows Developmental Therapy for Autistic Members Costs One-Third of Comparable ABA Therapy, Slashing Payer Spending by More Than 60%"},"content":{"rendered":"
\n

MCLEAN, Va.–(BUSINESS WIRE)–#Autism<\/a>–A new, three-year analysis of autism therapy claims data by Positive Development<\/a>, the leading provider of developmental therapy for autistic children and their families, shows that the company\u2019s developmental therapy model<\/a> costs 68% less, on average, per member per year, than the average cost of comparable Applied Behavior Analysis (ABA) therapy over the same period. Positive Development\u2019s analysis was conducted in partnership with one of its largest contracted payers, a regional, non-profit health plan in the mid-Atlantic.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nOver the period covered by the data analyzed, the non-profit health insurer\u2019s ABA therapy costs increased at a compounding rate of 28% year-over-year, making it one of the fastest-growing conditions from a cost perspective. Positive Development\u2019s average annual per member cost over that same period was more than two-thirds lower, despite contracting at significantly higher hourly rates than comparable average ABA rates.\n<\/p>\n

\n\u201cHealth plans are often hesitant to contract at higher rates, but they are essential for hiring qualified staff and making our lower intensity service offering financially sustainable,\u201d said Mike Suiters, Co-founder and CEO of Positive Development. \u201cThis data clearly shows that our therapy model is significantly more cost-effective than ABA when comparing annual per-capita cost, even at higher hourly rates.\u201d\n<\/p>\n

\nSuiters added, \u201cHaving an autism therapy option that costs two-thirds less is a win for payers looking for cost-effective solutions that deliver strong member outcomes and lower costs for all. It’s a win for families who have been requesting more care choices and needing more access to services. Positive Development is innovating in this space to create a value-based reimbursement model for our lower-intensity, lower cost, family-centered developmental therapy that we think will become the standard of care.”\n<\/p>\n

\n\u201cWe couldn\u2019t ask for a better partner in advancing value-based autism care,\u201d said Chad Pomeroy, President of Positive Development. \u201cWith ABA costs growing at unsustainable rates, payers need evidence-based, cost-effective alternatives. This analysis demonstrates developmental relationship-based therapy is a compelling path forward.\u201d\n<\/p>\n

\nAs commercial and Medicaid payers seek value-based care approaches to autism care, the findings highlight developmental therapy as a proven solution that supports families, improves outcomes and reduces utilization costs.\n<\/p>\n

\nTo learn more about Positive Development\u2019s affordable and transformative developmental therapy, please visit www.positivedevelopment.com<\/a> or follow company updates on:\n<\/p>\n

\nInstagram<\/a>\n<\/p>\n

\nFacebook<\/a>\n<\/p>\n

\nLinkedIn<\/a>\n<\/p>\n

\nAbout Positive Development<\/b>\n<\/p>\n

\nSince 2020, Positive Development has been on a mission to deliver developmental therapy to as many autistic children and families as possible. Positive Development\u2019s team represents dedicated parents, devoted family members, impassioned self-advocates and pioneering clinicians. Together, they have observed the transformative power of high-quality Developmental Relationship-Based Interventions (DRBI) therapy firsthand \u2013 personally, professionally and scientifically. As the largest provider of developmental therapy in the country, Positive Development is committed to broadening access to this life-changing approach while establishing best practices in clinical support. The company\u2019s dedication to outcomes measurement and evaluation benefits all families served.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nSuzy Smith
\n
PR Director, Positive Development
\n
suzy.smith@positivedevelopment.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MCLEAN, Va.–(BUSINESS WIRE)–#Autism–A new, three-year analysis of autism therapy claims data by Positive Development, the leading provider of developmental therapy for autistic children and their families, shows that the company\u2019s developmental therapy model costs 68% less, on average, per member per year, than the average cost of comparable Applied Behavior Analysis (ABA) therapy over the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62328","6":"format-standard","7":"category-industry"},"yoast_head":"\nAnalysis Shows Developmental Therapy for Autistic Members Costs One-Third of Comparable ABA Therapy, Slashing Payer Spending by More Than 60% - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Analysis Shows Developmental Therapy for Autistic Members Costs One-Third of Comparable ABA Therapy, Slashing Payer Spending by More Than 60% - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MCLEAN, Va.–(BUSINESS WIRE)–#Autism–A new, three-year analysis of autism therapy claims data by Positive Development, the leading provider of developmental therapy for autistic children and their families, shows that the company\u2019s developmental therapy model costs 68% less, on average, per member per year, than the average cost of comparable Applied Behavior Analysis (ABA) therapy over the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-09T18:05:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251209262653\/en\/1877367\/22\/Positive_Development_Logo_RGB_600x.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Analysis Shows Developmental Therapy for Autistic Members Costs One-Third of Comparable ABA Therapy, Slashing Payer Spending by More Than 60%\",\"datePublished\":\"2025-12-09T18:05:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\\\/\"},\"wordCount\":513,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251209262653\\\/en\\\/1877367\\\/22\\\/Positive_Development_Logo_RGB_600x.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\\\/\",\"name\":\"Analysis Shows Developmental Therapy for Autistic Members Costs One-Third of Comparable ABA Therapy, Slashing Payer Spending by More Than 60% - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251209262653\\\/en\\\/1877367\\\/22\\\/Positive_Development_Logo_RGB_600x.jpg\",\"datePublished\":\"2025-12-09T18:05:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251209262653\\\/en\\\/1877367\\\/22\\\/Positive_Development_Logo_RGB_600x.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251209262653\\\/en\\\/1877367\\\/22\\\/Positive_Development_Logo_RGB_600x.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Analysis Shows Developmental Therapy for Autistic Members Costs One-Third of Comparable ABA Therapy, Slashing Payer Spending by More Than 60%\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Analysis Shows Developmental Therapy for Autistic Members Costs One-Third of Comparable ABA Therapy, Slashing Payer Spending by More Than 60% - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/","og_locale":"en_US","og_type":"article","og_title":"Analysis Shows Developmental Therapy for Autistic Members Costs One-Third of Comparable ABA Therapy, Slashing Payer Spending by More Than 60% - Pharma Trend","og_description":"MCLEAN, Va.–(BUSINESS WIRE)–#Autism–A new, three-year analysis of autism therapy claims data by Positive Development, the leading provider of developmental therapy for autistic children and their families, shows that the company\u2019s developmental therapy model costs 68% less, on average, per member per year, than the average cost of comparable Applied Behavior Analysis (ABA) therapy over the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/","og_site_name":"Pharma Trend","article_published_time":"2025-12-09T18:05:56+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251209262653\/en\/1877367\/22\/Positive_Development_Logo_RGB_600x.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Analysis Shows Developmental Therapy for Autistic Members Costs One-Third of Comparable ABA Therapy, Slashing Payer Spending by More Than 60%","datePublished":"2025-12-09T18:05:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/"},"wordCount":513,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251209262653\/en\/1877367\/22\/Positive_Development_Logo_RGB_600x.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/","url":"https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/","name":"Analysis Shows Developmental Therapy for Autistic Members Costs One-Third of Comparable ABA Therapy, Slashing Payer Spending by More Than 60% - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251209262653\/en\/1877367\/22\/Positive_Development_Logo_RGB_600x.jpg","datePublished":"2025-12-09T18:05:56+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251209262653\/en\/1877367\/22\/Positive_Development_Logo_RGB_600x.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251209262653\/en\/1877367\/22\/Positive_Development_Logo_RGB_600x.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/analysis-shows-developmental-therapy-for-autistic-members-costs-one-third-of-comparable-aba-therapy-slashing-payer-spending-by-more-than-60\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Analysis Shows Developmental Therapy for Autistic Members Costs One-Third of Comparable ABA Therapy, Slashing Payer Spending by More Than 60%"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62328"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62328\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62328"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62328"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}